Prognostic value of p53 for high risk superficial bladder cancer with long-term followup.

[1]  N. Malats,et al.  P53 as a prognostic marker for bladder cancer: a meta-analysis and review. , 2005, The Lancet. Oncology.

[2]  M. Soloway.  Re: Schrier BPh, Hollander MP, van Rhijn BWG, Kiemeney LALM, Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004;45:292-6. , 2005, European urology.

[3]  L. Kiemeney,et al.  Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. , 2004, European urology.

[4]  T. Ebert,et al.  P53 accumulation in precursor lesions and early stages of bladder cancer , 2004, World Journal of Urology.

[5]  M. Parmar,et al.  Can p53 staining be used to identify patients with aggressive superficial bladder cancer? , 2003, Journal of Pathology.

[6]  N. Smith,et al.  The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. , 2003, The Journal of urology.

[7]  T. Ebert,et al.  p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer , 2000, European Urology.

[8]  K. Matsumoto,et al.  Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder. , 2000, International journal of oncology.

[9]  G. Adessi,et al.  Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. , 1999, The Journal of urology.

[10]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[11]  J. Cheville,et al.  Survival of patients with carcinoma in situ of the urinary bladder , 1999, Cancer.

[12]  H. Herr,et al.  Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. , 1997, British journal of urology.

[13]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[14]  T. Uchida,et al.  p53 mutations and prognosis in bladder tumors. , 1995, The Journal of urology.

[15]  C. Cordon-Cardo,et al.  Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. , 1994, The Journal of urology.

[16]  S. Groshen,et al.  p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. , 1993, The American journal of pathology.

[17]  L. Kiemeney,et al.  Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. , 1993, The Journal of urology.

[18]  C. Cordon-Cardo,et al.  Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. , 1993, Journal of the National Cancer Institute.

[19]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[20]  A B West,et al.  Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. , 1986, The Journal of urology.

[21]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .